A Case of Ulcerative Colitis with Prolonged Remission Following Azathioprine-Induced Pancytopenia
Intestinal Research
; : 85-89, 2008.
Article
in Ko
| WPRIM
| ID: wpr-186562
Responsible library:
WPRO
ABSTRACT
Azathioprine (AZA) is widely used for the treatment of inflammatory bowel disease. Bone marrow suppression is a common side effect with AZA treatment. However, data from AZA trials has indicated that a leukocyte count less than 5,000/mm3 was a good predictor of induction and maintenance of remission. Moreover, there is evidence that eradication of sensitized leukocytes by leukapheresis or bone marrow transplantation improves inflammatory bowel disease. We report a case of a patient who had a chronic relapse of ulcerative colitis requiring the frequent use of systemic steroids, but presented prolonged remission following AZA-induced severe pancytopenia. Also colonoscopy showed accelerated healing of diffuse active ulcers following just recovery from pancytopenia.
Key words
Full text:
1
Database:
WPRIM
Main subject:
Pancytopenia
/
Recurrence
/
Steroids
/
Azathioprine
/
Ulcer
/
Bone Marrow
/
Inflammatory Bowel Diseases
/
Colitis, Ulcerative
/
Colonoscopy
/
Bone Marrow Transplantation
Limits:
Humans
Language:
Ko
Journal:
Intestinal Research
Year:
2008
Document type:
Article